Optimal benefits for hematopoietic stem cell transplantation

A consensus opinion

Richard T. Maziarz, Stephanie Farnia, Patricia Martin, Krishna V Komanduri

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Variability in transplantation benefits may directly affect outcomes of individuals undergoing autologous or allogeneic hematopoietic stem cell transplantation procedures. The Financial Working Group of the National Marrow Donor Program-sponsored System Capacity Initiative addressed the issue of variable benefits and reviewed multiple transplantation benefit packages from both public and private payer organizations. On completion of the review, a consensus was obtained on defining a recipient benefit package that avoids major coverage gaps that could negatively influence patient outcomes. The recommendation was to encourage adoption of these benefits at a national level by payers, benefit brokers/consultants, and sales teams.

Original languageEnglish
Pages (from-to)1671-1676
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number11
DOIs
StatePublished - Jan 1 2014

Fingerprint

Hematopoietic Stem Cell Transplantation
Transplantation
Consultants
Bone Marrow
Tissue Donors

Keywords

  • Consensus
  • Hematopoietic stem cell transplantation

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Optimal benefits for hematopoietic stem cell transplantation : A consensus opinion. / Maziarz, Richard T.; Farnia, Stephanie; Martin, Patricia; Komanduri, Krishna V.

In: Biology of Blood and Marrow Transplantation, Vol. 20, No. 11, 01.01.2014, p. 1671-1676.

Research output: Contribution to journalArticle

Maziarz, Richard T. ; Farnia, Stephanie ; Martin, Patricia ; Komanduri, Krishna V. / Optimal benefits for hematopoietic stem cell transplantation : A consensus opinion. In: Biology of Blood and Marrow Transplantation. 2014 ; Vol. 20, No. 11. pp. 1671-1676.
@article{8b0c8f91b31347c588bca1af1a6690a6,
title = "Optimal benefits for hematopoietic stem cell transplantation: A consensus opinion",
abstract = "Variability in transplantation benefits may directly affect outcomes of individuals undergoing autologous or allogeneic hematopoietic stem cell transplantation procedures. The Financial Working Group of the National Marrow Donor Program-sponsored System Capacity Initiative addressed the issue of variable benefits and reviewed multiple transplantation benefit packages from both public and private payer organizations. On completion of the review, a consensus was obtained on defining a recipient benefit package that avoids major coverage gaps that could negatively influence patient outcomes. The recommendation was to encourage adoption of these benefits at a national level by payers, benefit brokers/consultants, and sales teams.",
keywords = "Consensus, Hematopoietic stem cell transplantation",
author = "Maziarz, {Richard T.} and Stephanie Farnia and Patricia Martin and Komanduri, {Krishna V}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.bbmt.2014.07.007",
language = "English",
volume = "20",
pages = "1671--1676",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Optimal benefits for hematopoietic stem cell transplantation

T2 - A consensus opinion

AU - Maziarz, Richard T.

AU - Farnia, Stephanie

AU - Martin, Patricia

AU - Komanduri, Krishna V

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Variability in transplantation benefits may directly affect outcomes of individuals undergoing autologous or allogeneic hematopoietic stem cell transplantation procedures. The Financial Working Group of the National Marrow Donor Program-sponsored System Capacity Initiative addressed the issue of variable benefits and reviewed multiple transplantation benefit packages from both public and private payer organizations. On completion of the review, a consensus was obtained on defining a recipient benefit package that avoids major coverage gaps that could negatively influence patient outcomes. The recommendation was to encourage adoption of these benefits at a national level by payers, benefit brokers/consultants, and sales teams.

AB - Variability in transplantation benefits may directly affect outcomes of individuals undergoing autologous or allogeneic hematopoietic stem cell transplantation procedures. The Financial Working Group of the National Marrow Donor Program-sponsored System Capacity Initiative addressed the issue of variable benefits and reviewed multiple transplantation benefit packages from both public and private payer organizations. On completion of the review, a consensus was obtained on defining a recipient benefit package that avoids major coverage gaps that could negatively influence patient outcomes. The recommendation was to encourage adoption of these benefits at a national level by payers, benefit brokers/consultants, and sales teams.

KW - Consensus

KW - Hematopoietic stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=84908052745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908052745&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2014.07.007

DO - 10.1016/j.bbmt.2014.07.007

M3 - Article

VL - 20

SP - 1671

EP - 1676

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 11

ER -